MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas ...

Trevi Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing the investigational therapy, Haduviotm (oral nalbuphine ER) for the treatment of chronic cough in idiopathic pulmonary ...

For kids who visit the hospital frequently, anxiety around even routine procedures might interfere with each visit and even ...